Suppression of the NF‑κB signaling pathway in colon cancer cells by the natural compound Riccardin D from Dumortierahirsute.

Molecular Medicine Reports
Huiping LiuXia Xue

Abstract

Colorectal cancer (CRC) is a major cause of mortality and morbidity. Chronic inflammation is closely associated with the development, progression and prognosis of the majority of intestinal malignancies. In recent years, targeting the nuclear factor (NF)‑κB signaling pathway for CRC therapy has become an attractive strategy. Riccardin D, a novel macrocyclicbis (bibenzyl) compound, was isolated from the Chinese liverwort plant. Previous studies have suggested that Riccardin D exerted chemo‑preventative effects against the intestinal malignancy formation. In the present study, cell counting kit‑8, Hochest 33258 staining, mitochondria membrane permeability assay, western blotting analysis, reverse transcription‑polymerase chain reaction, luciferase reporter gene assay and molecular modeling analysis were performed to detect the effect and mechanisms of Riccardin D on human colon cancer cells. The results demonstrated that Riccardin D significantly inhibited the growth of HT‑29 cells. In addition, the cDNA expression of cyclooxygenase‑2, and the protein expression and activity of NF‑κB and tumor necrosis factor‑α were downregulated; however, the protein expression of cleaved caspase‑3 and ‑9, and cleaved poly (adenosine diphosphate...Continue Reading

References

Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Jan 2, 2004·Journal of Computer-aided Molecular Design·Robin J RosenfeldArthur J Olson
Jun 7, 2006·Journal of Asian Natural Products Research·Zhi-Qiang LuHong-Xiang Lou
Feb 13, 2007·Molecular Cancer Research : MCR·Wade S SamowitzHans Albertsen
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kei SakamotoMasao Omata
Nov 6, 2009·Cellular & Molecular Immunology·Soly WangXiaoren Zhang
Jul 14, 2010·Nature Cell Biology·Hsiangling TeoVinay Tergaonkar
Oct 19, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·E Angela MurphyMartin D Carmichael
Jan 21, 2011·Current Cancer Drug Targets·Lidija Klampfer
Feb 15, 2011·Methods in Molecular Biology·Delira Robbins, Yunfeng Zhao
May 3, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Aristeidis G VaiopoulosAthanasios G Papavassiliou
Aug 27, 2013·International Journal of Molecular Sciences·Sally TemrazAli Shamseddine
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jun 20, 2014·World Journal of Gastroenterology : WJG·Gemma BinefaManuel Medina-Hayas
Aug 12, 2014·World Journal of Gastroenterology : WJG·Francesco MarianiLuca Roncucci
May 21, 2015·World Journal of Experimental Medicine·Miguel Angel Chiurillo

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
electrophoresis
PCR
Assay
transfection
X-ray

Software Mentioned

Alpha Ease FC
SPSS
Auto Dock
Sybyl
X Suite
Auto Dock Vina
PASW Statistics

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.